Skip to content

Investigating Transcutaneous Vagal Nerve Stimulations Impact on Elderly Chronic Musculoskeletal Pain

Effect of Transcutaneous Vagal Nerve Stimulation on Chronic Pain of Musculoskeletal Origin in Elderly: A Quasi-Experimental Study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085406
Enrollment
76
Registered
2025-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M138- Other specified arthritis

Interventions

Intervention1: Transverse vagal nerve stimulation: Participants will be divided into two groups, Subjects in group “a ? will receive electrical stimulation in the external auricular nerve territory of

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects of either gender above 60 years of age. 2. Subjects diagnosed to have chronic pain based on Diagnostic criteria for chronic pain-ACTTION, American Pain Society Pain taxonomy. 3. Subjects belonging to Grade II to Grade IV on Chronic pain Grade scale.

Exclusion criteria

Exclusion criteria: Subject with known cardiac diseases including disorder of conduction, arrhythmias, or ischemic heart disease. 2. Subjects with programmable devices like insulin pumps or pacemakers in situ. 3. Subject using implanted or nonimplanted hearing aids. 4. Subject suffering from Benign paroxysmal positional vertigo or other known vestibular disorder. 5. Subjects with a history of or diagnosis of cerebral vascular accident in the past. 6. Subject with peripheral neuropathies. 7. Subject who recently underwent middle or inner ear surgery (like Tympanoplasty) 8. Subject with a medial ear infection- Otitis media.

Design outcomes

Primary

MeasureTime frame
1)McGill Pain Questionnaire 2)Central sensitization inventory 3)SF-12 quality of life 4)Beck’s depression inventory 5)The Brief Pain Inventory 6)Visual Analog ScaleTimepoint: 2 weeks and 4 weeks

Secondary

MeasureTime frame
SF-12 quality of life Timepoint: 2weeks & 4 weeks

Countries

India

Contacts

Public ContactMr Shyam Krishnan k

Kasturba medical college, Mangalore, MAHE

krish.shyam@manipal.edu09880072564

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026